US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class I · High risk Terminated

BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate

Reason Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC NDC 54365-400-33 D-0268-2021
Class I · High risk Terminated

ChloraPrep One-Step 2% w/v chlorhexidine gluconate

Reason Microbial Contamination of Non-Sterile Product: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC D-0267-2021
Class I · High risk Terminated

ChloraPrep With Tint 2% w/v chlorhexidine gluconate

Reason Microbial Contamination of Non-Sterile Products:Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC D-0266-2021
Class I · High risk Terminated

BD ChloraPrep Clear

Reason Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

CareFusion 213, LLC NDC 54365-400-32 D-0265-2021
Class III · Low risk Terminated

Clonazepam Orally Disintegrating Tablets

Reason Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine

Sun Pharmaceutical Industries INC NDC 57664-783-86 D-1445-2020
Class III · Low risk Terminated

Skin Medica Acne System

Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Allergan PLC D-1410-2020
Class III · Low risk Terminated

Skin Medica Acne Treatment Lotion

Reason SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.

Allergan PLC NDC 0023-4965-02 D-1409-2020
Class II · Moderate risk Ongoing

Metformin Hydrochloride Extended-Release Tablets USP

Reason CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Granules Pharmaceuticals Inc NDC 70010-492-01 D-1386-2020
Class II · Moderate risk Terminated

Vancomycin HCL 1.5 mg Edge Pharma

Reason Labeling: Label Error on Declared Strength

Edge Pharma, LLC NDC 05446-1458-01 D-1562-2020
Class II · Moderate risk Terminated

Yohimbine HCL 5.4mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1443-2020
Class II · Moderate risk Terminated

Vardenafil 20 mg Troche

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1442-2020
Class II · Moderate risk Terminated

Testosterone/Anastrozole Pellet 100/6 mg

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1441-2020
Class II · Moderate risk Terminated

Tadalafil 7 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1440-2020
Class II · Moderate risk Terminated

Tadalafil 3 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1439-2020
Class II · Moderate risk Terminated

Tadalafil 26 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1438-2020
Class II · Moderate risk Terminated

Tadalafil 18 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1437-2020
Class II · Moderate risk Terminated

Tadalafil 12 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1436-2020
Class II · Moderate risk Terminated

Sildenafil 50 mg Troche

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1435-2020
Class II · Moderate risk Terminated

Progesterone 200 mg Troche

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1431-2020
Class II · Moderate risk Terminated

Progesterone

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1430-2020